Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomics and inflammatory bowel disease.

S Schreiber1, J Hampe

  • 1Ist Department of Medicine, Christian-Albrechts-University, Kiel, Germany. s.schreiber@mucosa.de

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary

Genomic technologies are revolutionizing inflammatory bowel disease (IBD) research by identifying genetic variations and pathways. This advances understanding of IBD causes and inflammation, paving the way for targeted therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between olfactory function and quality of life in COVID-19 patients.

Rhinology·2026
Same author

Simvastatin impairs fracture healing under ischemic conditions.

Frontiers in pharmacology·2025
Same author

scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome.

Nature communications·2025
Same author

[Value of retrograde femoral nailing : Pros and cons].

Unfallchirurgie (Heidelberg, Germany)·2025
Same author

Zeitschrift fur Gastroenterologie·2024
Same author

Zeitschrift fur Gastroenterologie·2023

Area of Science:

  • Genomics
  • Molecular Biology
  • Gastroenterology

Background:

  • Inflammatory bowel disease (IBD) etiology and pathophysiology are complex.
  • Genomic technologies provide novel approaches to investigate IBD.
  • Understanding genetic predispositions is crucial for IBD research.

Purpose of the Study:

  • To explore the application of genomic technologies in IBD research.
  • To identify gene variations associated with IBD susceptibility.
  • To investigate the potential of pharmacogenetics and gene expression in IBD.

Main Methods:

  • Genome-wide linkage studies to identify susceptibility regions.
  • Linkage disequilibrium and candidate gene methods to pinpoint molecular variants.
  • Global gene expression technologies to discover inflammatory pathways.

Related Experiment Videos

Main Results:

  • Replicated IBD susceptibility regions identified on chromosomes 6, 12, and 16.
  • Ongoing efforts to define specific molecular variants within these regions.
  • Potential for pharmacogenetic studies to guide targeted IBD therapies.

Conclusions:

  • Genomic methodologies are significantly advancing IBD research.
  • These approaches offer novel insights into IBD etiology and pathophysiology.
  • Future research will likely uncover new therapeutic targets for chronic intestinal inflammation.